Canadian Drug Cos. To Pay $34M For Selling Phony Products

Law360 (April 13, 2018, 10:16 PM EDT) -- A Canadian online pharmacy and its owner were ordered to pay $34 million after admitting to selling misbranded and counterfeit drugs in the U.S., Montana federal prosecutors said Friday, ending a 17-year business that allegedly sold phony cancer drugs with no active ingredients.

Kris Thorkelson and companies connected to him — Canada Drugs, Rockley Ventures and River East Supplies — admitted to widespread illegal sales of the drugs on Friday and were sentenced in Montana federal court, prosecutors said.

The U.S. Department of Justice and the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.